ID   HSP7C_MOUSE             Reviewed;         646 AA.
AC   P63017; P08109; P12225; Q3U6R0; Q3U764; Q3U7D7; Q3U7E2; Q3U9B4; Q3U9G0;
AC   Q3UGM0; Q5FWJ6; Q62373; Q62374; Q62375; Q6NZD0;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   28-JAN-2026, entry version 196.
DE   RecName: Full=Heat shock cognate 71 kDa protein {ECO:0000305};
DE            EC=3.6.4.10 {ECO:0000250|UniProtKB:P11142};
DE   AltName: Full=Heat shock 70 kDa protein 8;
GN   Name=Hspa8 {ECO:0000312|MGI:MGI:105384};
GN   Synonyms=Hsc70 {ECO:0000303|PubMed:10095055}, Hsc73
GN   {ECO:0000303|PubMed:8682318};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3334718; DOI=10.1016/0012-1606(88)90073-5;
RA   Giebel L.B., Dworniczak B.P., Bautz E.K.F.;
RT   "Developmental regulation of a constitutively expressed mouse mRNA encoding
RT   a 72-kDa heat shock-like protein.";
RL   Dev. Biol. 125:200-207(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=129; TISSUE=Mammary gland;
RX   PubMed=8682318; DOI=10.1016/0378-1119(96)00169-2;
RA   Soulier S., Vilotte J.-L., L'Huillier P.J., Mercier J.-C.;
RT   "Developmental regulation of murine integrin beta 1 subunit- and Hsc73-
RT   encoding genes in mammary gland: sequence of a new mouse Hsc73 cDNA.";
RL   Gene 172:285-289(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=129;
RX   PubMed=10095055; DOI=10.1016/s0167-4781(98)00285-1;
RA   Hunt C.R., Parsian A.J., Goswami P.C., Kozak C.A.;
RT   "Characterization and expression of the mouse Hsc70 gene.";
RL   Biochim. Biophys. Acta 1444:315-325(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and DBA/2J;
RC   TISSUE=Amnion, Bone marrow, Heart, Kidney, Liver, Stomach, Thymus, and
RC   Urinary bladder;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and FVB/N;
RC   TISSUE=Brain, Embryo, Embryonic germ cell, Eye, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 4-49; 57-71; 77-102; 113-155; 160-188; 221-246;
RP   300-319; 326-342; 349-357; 362-384; 424-447; 540-550 AND 584-597, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=C57BL/6J, and OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Kang S.U., Klug S., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 333-383; 438-452 AND 580-587.
RX   PubMed=2251119; DOI=10.1093/nar/18.22.6565;
RA   Liu J., Maxwell E.S.;
RT   "Mouse U14 snRNA is encoded in an intron of the mouse cognate hsc70 heat
RT   shock gene.";
RL   Nucleic Acids Res. 18:6565-6571(1990).
RN   [8]
RP   INTERACTION WITH HSPH1.
RX   PubMed=9675148; DOI=10.1006/bbrc.1998.8979;
RA   Hatayama T., Yasuda K., Yasuda K.;
RT   "Association of HSP105 with HSC70 in high molecular mass complexes in mouse
RT   FM3A cells.";
RL   Biochem. Biophys. Res. Commun. 248:395-401(1998).
RN   [9]
RP   INTERACTION WITH HSPH1.
RX   PubMed=15292236; DOI=10.1074/jbc.m407947200;
RA   Yamagishi N., Ishihara K., Hatayama T.;
RT   "Hsp105alpha suppresses Hsc70 chaperone activity by inhibiting Hsc70 ATPase
RT   activity.";
RL   J. Biol. Chem. 279:41727-41733(2004).
RN   [10]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [11]
RP   INTERACTION WITH IRAK1BP1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17233114; DOI=10.1089/dna.2006.25.704;
RA   Haag Breese E., Uversky V.N., Georgiadis M.M., Harrington M.A.;
RT   "The disordered amino-terminus of SIMPL interacts with members of the 70-
RT   kDa heat-shock protein family.";
RL   DNA Cell Biol. 25:704-714(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [13]
RP   INTERACTION WITH BAG3; HSPB8 AND STUB1 IN CASA COMPLEX.
RX   PubMed=20060297; DOI=10.1016/j.cub.2009.11.022;
RA   Arndt V., Dick N., Tawo R., Dreiseidler M., Wenzel D., Hesse M.,
RA   Fuerst D.O., Saftig P., Saint R., Fleischmann B.K., Hoch M., Hoehfeld J.;
RT   "Chaperone-assisted selective autophagy is essential for muscle
RT   maintenance.";
RL   Curr. Biol. 20:143-148(2010).
RN   [14]
RP   INTERACTION WITH GIMAP5; BCL2L1 AND MCL1.
RX   PubMed=21502331; DOI=10.1084/jem.20101192;
RA   Chen Y., Yu M., Dai X., Zogg M., Wen R., Weiler H., Wang D.;
RT   "Critical role for Gimap5 in the survival of mouse hematopoietic stem and
RT   progenitor cells.";
RL   J. Exp. Med. 208:923-935(2011).
RN   [15]
RP   METHYLATION AT LYS-561.
RX   PubMed=23921388; DOI=10.1074/jbc.m113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human methyltransferase
RT   modulating Hsp70 function through lysine methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-108; LYS-246; LYS-319; LYS-328;
RP   LYS-512; LYS-524 AND LYS-601, SUCCINYLATION [LARGE SCALE ANALYSIS] AT
RP   LYS-319 AND LYS-512, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Embryonic fibroblast, and Liver;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [17]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-469, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH GPX4.
RX   PubMed=30718432; DOI=10.1073/pnas.1819728116;
RA   Wu Z., Geng Y., Lu X., Shi Y., Wu G., Zhang M., Shan B., Pan H., Yuan J.;
RT   "Chaperone-mediated autophagy is involved in the execution of
RT   ferroptosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 116:2996-3005(2019).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of cellular
CC       processes, including protection of the proteome from stress, folding
CC       and transport of newly synthesized polypeptides, chaperone-mediated
CC       autophagy, activation of proteolysis of misfolded proteins, formation
CC       and dissociation of protein complexes, and antigen presentation
CC       (PubMed:30718432). Plays a pivotal role in the protein quality control
CC       system, ensuring the correct folding of proteins, the re-folding of
CC       misfolded proteins and controlling the targeting of proteins for
CC       subsequent degradation. This is achieved through cycles of ATP binding,
CC       ATP hydrolysis and ADP release, mediated by co-chaperones. The co-
CC       chaperones have been shown to not only regulate different steps of the
CC       ATPase cycle of HSP70, but they also have an individual specificity
CC       such that one co-chaperone may promote folding of a substrate while
CC       another may promote degradation. The affinity of HSP70 for polypeptides
CC       is regulated by its nucleotide bound state. In the ATP-bound form, it
CC       has a low affinity for substrate proteins. However, upon hydrolysis of
CC       the ATP to ADP, it undergoes a conformational change that increases its
CC       affinity for substrate proteins. HSP70 goes through repeated cycles of
CC       ATP hydrolysis and nucleotide exchange, which permits cycles of
CC       substrate binding and release. The HSP70-associated co-chaperones are
CC       of three types: J-domain co-chaperones HSP40s (stimulate ATPase
CC       hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as
CC       BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-
CC       bound state thereby promoting substrate release), and the TPR domain
CC       chaperones such as HOPX and STUB1. Plays a critical role in
CC       mitochondrial import, delivers preproteins to the mitochondrial import
CC       receptor TOMM70. Acts as a repressor of transcriptional activation.
CC       Inhibits the transcriptional coactivator activity of CITED1 on Smad-
CC       mediated transcription. Component of the PRP19-CDC5L complex that forms
CC       an integral part of the spliceosome and is required for activating pre-
CC       mRNA splicing. May have a scaffolding role in the spliceosome assembly
CC       as it contacts all other components of the core complex. Binds
CC       bacterial lipopolysaccharide (LPS) and mediates LPS-induced
CC       inflammatory response, including TNF secretion by monocytes. Substrate
CC       recognition component in chaperone-mediated autophagy (CMA), a
CC       selective protein degradation process that mediates degradation of
CC       proteins with a -KFERQ motif: HSPA8/HSC70 specifically recognizes and
CC       binds cytosolic proteins bearing a -KFERQ motif and promotes their
CC       recruitment to the surface of the lysosome where they bind to lysosomal
CC       protein LAMP2 (PubMed:30718432). KFERQ motif-containing proteins are
CC       eventually transported into the lysosomal lumen where they are degraded
CC       (PubMed:30718432). In conjunction with LAMP2, facilitates MHC class II
CC       presentation of cytoplasmic antigens by guiding antigens to the
CC       lysosomal membrane for interaction with LAMP2 which then elicits MHC
CC       class II presentation of peptides to the cell membrane. Participates in
CC       the ER-associated degradation (ERAD) quality control pathway in
CC       conjunction with J domain-containing co-chaperones and the E3 ligase
CC       STUB1. It is recruited to clathrin-coated vesicles through its
CC       interaction with DNAJC6 leading to activation of HSPA8/HSC70 ATPase
CC       activity and therefore uncoating of clathrin-coated vesicles (By
CC       similarity). {ECO:0000250|UniProtKB:P11142,
CC       ECO:0000250|UniProtKB:P19120, ECO:0000269|PubMed:30718432}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.10;
CC         Evidence={ECO:0000250|UniProtKB:P11142};
CC   -!- SUBUNIT: Component of the chaperone-assisted selective autophagy (CASA)
CC       complex consisting of BAG3, HSPA8/HSC70, HSPB8 and STUB1/CHIP
CC       (PubMed:20060297). Identified in a IGF2BP1-dependent mRNP granule
CC       complex containing untranslated mRNAs (By similarity). Interacts with
CC       PACRG (By similarity). Interacts with DNAJC7 (By similarity). Interacts
CC       with DNAJB12 (via J domain) (By similarity). Interacts with DNAJB14
CC       (via J domain) (By similarity). Interacts (via C-terminus) with the E3
CC       ligase STUB1 forming a 210 kDa complex of one STUB1 and two HSPA8
CC       molecules (By similarity). Interacts with CITED1 (via N-terminus); the
CC       interaction suppresses the association of CITED1 to p300/CBP and Smad-
CC       mediated transcription transactivation (By similarity). Component of
CC       the PRP19-CDC5L splicing complex composed of a core complex comprising
CC       a homotetramer of PRPF19, CDC5L, PLRG1 and BCAS2, and at least three
CC       less stably associated proteins CTNNBL1, CWC15 and HSPA8 (By
CC       similarity). Interacts with IRAK1BP1 and HSPH1/HSP105 (PubMed:15292236,
CC       PubMed:17233114, PubMed:9675148). Interacts with TRIM5 (By similarity).
CC       Part of a complex composed at least of ASH2L, EMSY, HCFC1, HSPA8,
CC       CCAR2, MATR3, MKI67, RBBP5, TUBB2A, WDR5 and ZNF335; this complex may
CC       have a histone H3-specific methyltransferase activity (By similarity).
CC       Following LPS binding, may form a complex with CXCR4, GDF5 and HSP90AA1
CC       (By similarity). Interacts with PRKN (By similarity). Interacts with
CC       FOXP3 (By similarity). Interacts with DNAJC9 (via J domain) (By
CC       similarity). Interacts with MLLT11 (By similarity). Interacts with
CC       RNF207 (By similarity). Interacts with DNAJC21 (By similarity).
CC       Interacts with DNAJB2 (By similarity). Interacts with TTC1 (via TPR
CC       repeats) (By similarity). Interacts with SGTA (via TPR repeats) (By
CC       similarity). Interacts with HSF1 (via transactivation domain) (By
CC       similarity). Interacts with HOPX, STUB1, HSP40, HSP90, BAG2 and BAG3
CC       (By similarity). Interacts with DNAJC12 (By similarity). Interacts with
CC       HSPC138 (By similarity). Interacts with ZMYND10 (By similarity).
CC       Interacts with VGF-derived peptide TLQP-21 (By similarity). Interacts
CC       with BCL2L1, GIMAP5 and MCL1; the interaction with BCL2L1 or MCL1 is
CC       impaired in the absence of GIMAP5 (PubMed:21502331). Interacts with
CC       NLPR12 (By similarity). Interacts with TTC4 (By similarity). Interacts
CC       with TOMM70; the interaction is required for preprotein mitochondrial
CC       import (By similarity). May interact with DNJC9; the interaction seems
CC       to be histone-dependent (By similarity). Interacts with BAG5 and JPH2;
CC       the interaction with JPH2 is increased in the presence of BAG5 (By
CC       similarity). Interacts with DNAJC6 (via J domain) in an ATP-dependent
CC       manner; this interaction stimulates the HSPA8's ATPase activity. Forms
CC       a complex composed of HSPA8, CLTC and DNAJC6 (By similarity). Interacts
CC       with HSPA8; this interaction modulates migratory and antigen-presenting
CC       capacities of dendritic cells (By similarity).
CC       {ECO:0000250|UniProtKB:P11142, ECO:0000250|UniProtKB:P19120,
CC       ECO:0000250|UniProtKB:P63018, ECO:0000269|PubMed:15292236,
CC       ECO:0000269|PubMed:17233114, ECO:0000269|PubMed:20060297,
CC       ECO:0000269|PubMed:21502331, ECO:0000269|PubMed:9675148}.
CC   -!- INTERACTION:
CC       P63017; O88447: Klc1; NbExp=3; IntAct=EBI-433443, EBI-301550;
CC       P63017; P43883: Plin2; NbExp=3; IntAct=EBI-433443, EBI-16156700;
CC       P63017; Q9DBG5: Plin3; NbExp=2; IntAct=EBI-433443, EBI-643495;
CC       P63017; O41974: GAMMAHV.ORF73; Xeno; NbExp=3; IntAct=EBI-433443, EBI-6933128;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11142}.
CC       Melanosome {ECO:0000250|UniProtKB:P11142}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:P11142}. Cell membrane
CC       {ECO:0000250|UniProtKB:P11142}. Lysosome membrane
CC       {ECO:0000250|UniProtKB:P11142}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P11142}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P11142}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs. Translocates rapidly from the
CC       cytoplasm to the nuclei, and especially to the nucleoli, upon heat
CC       shock. {ECO:0000250|UniProtKB:P11142}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- INDUCTION: Constitutively synthesized.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known as
CC       the ATPase domain) is responsible for binding and hydrolyzing ATP. The
CC       C-terminal substrate-binding domain (SBD) (also known as peptide-
CC       binding domain) binds to the client/substrate proteins. The two domains
CC       are allosterically coupled so that, when ATP is bound to the NBD, the
CC       SBD binds relatively weakly to clients. When ADP is bound in the NBD, a
CC       conformational change enhances the affinity of the SBD for client
CC       proteins. {ECO:0000250|UniProtKB:P11142}.
CC   -!- PTM: Acetylated. {ECO:0000250|UniProtKB:P11142}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: Trimethylation at Lys-561 reduces fibrillar SNCA binding.
CC       {ECO:0000250|UniProtKB:P11142}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE31508.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M19141; AAA37869.1; -; mRNA.
DR   EMBL; U27129; AAC52836.1; -; mRNA.
DR   EMBL; U73744; AAB18391.1; -; Genomic_DNA.
DR   EMBL; AK035286; BAC29016.1; -; mRNA.
DR   EMBL; AK075935; BAC36065.1; -; mRNA.
DR   EMBL; AK145579; BAE26523.1; -; mRNA.
DR   EMBL; AK146708; BAE27374.1; -; mRNA.
DR   EMBL; AK146985; BAE27588.1; -; mRNA.
DR   EMBL; AK147864; BAE28187.1; -; mRNA.
DR   EMBL; AK150474; BAE29591.1; -; mRNA.
DR   EMBL; AK150498; BAE29612.1; -; mRNA.
DR   EMBL; AK150701; BAE29780.1; -; mRNA.
DR   EMBL; AK150958; BAE29990.1; -; mRNA.
DR   EMBL; AK151065; BAE30081.1; -; mRNA.
DR   EMBL; AK151127; BAE30135.1; -; mRNA.
DR   EMBL; AK151287; BAE30272.1; -; mRNA.
DR   EMBL; AK151435; BAE30398.1; -; mRNA.
DR   EMBL; AK151516; BAE30465.1; -; mRNA.
DR   EMBL; AK151537; BAE30484.1; -; mRNA.
DR   EMBL; AK151775; BAE30681.1; -; mRNA.
DR   EMBL; AK151808; BAE30707.1; -; mRNA.
DR   EMBL; AK151865; BAE30753.1; -; mRNA.
DR   EMBL; AK151892; BAE30776.1; -; mRNA.
DR   EMBL; AK151948; BAE30822.1; -; mRNA.
DR   EMBL; AK151997; BAE30861.1; -; mRNA.
DR   EMBL; AK152598; BAE31346.1; -; mRNA.
DR   EMBL; AK152697; BAE31427.1; -; mRNA.
DR   EMBL; AK152703; BAE31432.1; -; mRNA.
DR   EMBL; AK152803; BAE31508.1; ALT_FRAME; mRNA.
DR   EMBL; AK153032; BAE31664.1; -; mRNA.
DR   EMBL; AK153834; BAE32204.1; -; mRNA.
DR   EMBL; AK159479; BAE35116.1; -; mRNA.
DR   EMBL; AK164000; BAE37581.1; -; mRNA.
DR   EMBL; AK166643; BAE38912.1; -; mRNA.
DR   EMBL; AK166721; BAE38970.1; -; mRNA.
DR   EMBL; AK166767; BAE39005.1; -; mRNA.
DR   EMBL; AK166776; BAE39012.1; -; mRNA.
DR   EMBL; AK166808; BAE39036.1; -; mRNA.
DR   EMBL; AK166830; BAE39053.1; -; mRNA.
DR   EMBL; AK166846; BAE39065.1; -; mRNA.
DR   EMBL; AK166861; BAE39076.1; -; mRNA.
DR   EMBL; AK166873; BAE39084.1; -; mRNA.
DR   EMBL; AK166908; BAE39109.1; -; mRNA.
DR   EMBL; AK166910; BAE39111.1; -; mRNA.
DR   EMBL; AK166913; BAE39113.1; -; mRNA.
DR   EMBL; AK166933; BAE39127.1; -; mRNA.
DR   EMBL; AK167043; BAE39211.1; -; mRNA.
DR   EMBL; AK167121; BAE39269.1; -; mRNA.
DR   EMBL; AK167122; BAE39270.1; -; mRNA.
DR   EMBL; AK167134; BAE39280.1; -; mRNA.
DR   EMBL; AK167163; BAE39304.1; -; mRNA.
DR   EMBL; AK167218; BAE39344.1; -; mRNA.
DR   EMBL; AK167229; BAE39353.1; -; mRNA.
DR   EMBL; AK167845; BAE39865.1; -; mRNA.
DR   EMBL; AK167910; BAE39917.1; -; mRNA.
DR   EMBL; AK168492; BAE40379.1; -; mRNA.
DR   EMBL; AK168519; BAE40398.1; -; mRNA.
DR   EMBL; AK168542; BAE40419.1; -; mRNA.
DR   EMBL; AK168711; BAE40553.1; -; mRNA.
DR   EMBL; AK168750; BAE40590.1; -; mRNA.
DR   EMBL; AK168776; BAE40612.1; -; mRNA.
DR   EMBL; AK168887; BAE40704.1; -; mRNA.
DR   EMBL; AK168934; BAE40745.1; -; mRNA.
DR   EMBL; AK169093; BAE40876.1; -; mRNA.
DR   EMBL; AK169179; BAE40957.1; -; mRNA.
DR   EMBL; AK169236; BAE41004.1; -; mRNA.
DR   EMBL; AK169293; BAE41049.1; -; mRNA.
DR   EMBL; BC006722; AAH06722.1; -; mRNA.
DR   EMBL; BC066191; AAH66191.1; -; mRNA.
DR   EMBL; BC085486; AAH85486.1; -; mRNA.
DR   EMBL; BC089322; AAH89322.1; -; mRNA.
DR   EMBL; BC089457; AAH89457.1; -; mRNA.
DR   EMBL; BC106193; AAI06194.1; -; mRNA.
DR   EMBL; X54401; CAA38267.1; -; Genomic_DNA.
DR   EMBL; X54402; CAA38268.1; -; Genomic_DNA.
DR   EMBL; X54403; CAA38269.1; -; Genomic_DNA.
DR   CCDS; CCDS23083.1; -.
DR   PIR; A45935; A45935.
DR   PIR; JC4853; JC4853.
DR   RefSeq; NP_112442.2; NM_031165.4.
DR   PDB; 3CQX; X-ray; 2.30 A; A/B=1-381.
DR   PDBsum; 3CQX; -.
DR   AlphaFoldDB; P63017; -.
DR   SMR; P63017; -.
DR   BioGRID; 200428; 182.
DR   ComplexPortal; CPX-5825; PRP19-CDC5L complex.
DR   CORUM; P63017; -.
DR   DIP; DIP-32353N; -.
DR   FunCoup; P63017; 2937.
DR   IntAct; P63017; 51.
DR   MINT; P63017; -.
DR   STRING; 10090.ENSMUSP00000015800; -.
DR   ChEMBL; CHEMBL5169139; -.
DR   CarbonylDB; P63017; -.
DR   GlyGen; P63017; 7 sites, 5 N-linked glycans (5 sites), 1 O-linked glycan (2 sites).
DR   iPTMnet; P63017; -.
DR   MetOSite; P63017; -.
DR   PhosphoSitePlus; P63017; -.
DR   SwissPalm; P63017; -.
DR   REPRODUCTION-2DPAGE; IPI00323357; -.
DR   REPRODUCTION-2DPAGE; P63017; -.
DR   REPRODUCTION-2DPAGE; Q6NZD0; -.
DR   CPTAC; non-CPTAC-3713; -.
DR   jPOST; P63017; -.
DR   PaxDb; 10090-ENSMUSP00000015800; -.
DR   PeptideAtlas; P63017; -.
DR   ProteomicsDB; 273196; -.
DR   Pumba; P63017; -.
DR   Antibodypedia; 3675; 1143 antibodies from 43 providers.
DR   DNASU; 15481; -.
DR   Ensembl; ENSMUST00000015800.16; ENSMUSP00000015800.10; ENSMUSG00000015656.18.
DR   GeneID; 15481; -.
DR   KEGG; mmu:15481; -.
DR   UCSC; uc009ozx.3; mouse.
DR   AGR; MGI:105384; -.
DR   CTD; 3312; -.
DR   MGI; MGI:105384; Hspa8.
DR   VEuPathDB; HostDB:ENSMUSG00000015656; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   GeneTree; ENSGT00950000183206; -.
DR   HOGENOM; CLU_005965_3_0_1; -.
DR   InParanoid; P63017; -.
DR   OMA; AYTKNQD; -.
DR   OrthoDB; 2401965at2759; -.
DR   PhylomeDB; P63017; -.
DR   Reactome; R-MMU-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-MMU-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-MMU-3371568; Attenuation phase.
DR   Reactome; R-MMU-3371571; HSF1-dependent transactivation.
DR   Reactome; R-MMU-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-MMU-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-MMU-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-MMU-6798695; Neutrophil degranulation.
DR   Reactome; R-MMU-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-MMU-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-MMU-8876725; Protein methylation.
DR   Reactome; R-MMU-888590; GABA synthesis, release, reuptake and degradation.
DR   Reactome; R-MMU-9833482; PKR-mediated signaling.
DR   BioGRID-ORCS; 15481; 32 hits in 78 CRISPR screens.
DR   CD-CODE; 8F289D40; ELVA.
DR   CD-CODE; CE726F99; Postsynaptic density.
DR   EvolutionaryTrace; P63017; -.
DR   PRO; PR:P63017; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; P63017; protein.
DR   Bgee; ENSMUSG00000015656; Expressed in embryonic post-anal tail and 124 other cell types or tissues.
DR   ExpressionAtlas; P63017; baseline and differential.
DR   GO; GO:0032279; C:asymmetric synapse; ISO:GO_Central.
DR   GO; GO:0005776; C:autophagosome; ISO:GO_Central.
DR   GO; GO:0030424; C:axon; ISO:GO_Central.
DR   GO; GO:0009986; C:cell surface; ISO:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:AgBase.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0030425; C:dendrite; ISO:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; ISO:GO_Central.
DR   GO; GO:0043197; C:dendritic spine; ISO:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:MGI.
DR   GO; GO:0005615; C:extracellular space; ISO:GO_Central.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0005882; C:intermediate filament; ISO:GO_Central.
DR   GO; GO:0005770; C:late endosome; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031906; C:late endosome lumen; TAS:Reactome.
DR   GO; GO:1990836; C:lysosomal matrix; ISO:MGI.
DR   GO; GO:0005765; C:lysosomal membrane; ISS:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005874; C:microtubule; ISO:GO_Central.
DR   GO; GO:0043209; C:myelin sheath; HDA:UniProtKB.
DR   GO; GO:0044309; C:neuron spine; ISO:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; ISO:GO_Central.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; ISO:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:MGI.
DR   GO; GO:0001917; C:photoreceptor inner segment; ISO:GO_Central.
DR   GO; GO:0098684; C:photoreceptor ribbon synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098794; C:postsynapse; ISO:GO_Central.
DR   GO; GO:0014069; C:postsynaptic density; ISO:GO_Central.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0101031; C:protein folding chaperone complex; ISO:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; ISO:GO_Central.
DR   GO; GO:0000974; C:Prp19 complex; ISS:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; NAS:ComplexPortal.
DR   GO; GO:0008021; C:synaptic vesicle; ISO:GO_Central.
DR   GO; GO:0043195; C:terminal bouton; ISO:GO_Central.
DR   GO; GO:0031686; F:A1 adenosine receptor binding; ISO:GO_Central.
DR   GO; GO:0043531; F:ADP binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; ISO:GO_Central.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:MGI.
DR   GO; GO:0140545; F:ATP-dependent protein disaggregase activity; ISO:GO_Central.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; ISO:GO_Central.
DR   GO; GO:1990833; F:clathrin-uncoating ATPase activity; ISO:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; ISO:GO_Central.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; ISO:GO_Central.
DR   GO; GO:0031072; F:heat shock protein binding; ISO:GO_Central.
DR   GO; GO:0042277; F:peptide binding; ISO:GO_Central.
DR   GO; GO:0001786; F:phosphatidylserine binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1904593; F:prostaglandin binding; ISO:GO_Central.
DR   GO; GO:0044183; F:protein folding chaperone; IBA:GO_Central.
DR   GO; GO:0051087; F:protein-folding chaperone binding; ISO:GO_Central.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IDA:UniProtKB.
DR   GO; GO:0048018; F:receptor ligand activity; ISO:GO_Central.
DR   GO; GO:0003723; F:RNA binding; ISO:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:GO_Central.
DR   GO; GO:0051082; F:unfolded protein binding; IPI:MGI.
DR   GO; GO:0046034; P:ATP metabolic process; ISO:GO_Central.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0034605; P:cellular response to heat; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; IDA:UniProtKB.
DR   GO; GO:1904764; P:chaperone-mediated autophagy translocation complex disassembly; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0072318; P:clathrin coat disassembly; IDA:UniProtKB.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0044829; P:host-mediated activation of viral genome replication; IMP:AgBase.
DR   GO; GO:0044788; P:host-mediated perturbation of viral process; IMP:AgBase.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0061738; P:late endosomal microautophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0098880; P:maintenance of postsynaptic specialization structure; ISO:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; NAS:ComplexPortal.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISO:GO_Central.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:1900226; P:negative regulation of NLRP3 inflammasome complex assembly; ISO:GO_Central.
DR   GO; GO:1902904; P:negative regulation of supramolecular fiber organization; ISO:GO_Central.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:GO_Central.
DR   GO; GO:0160020; P:positive regulation of ferroptosis; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:GO_Central.
DR   GO; GO:0097214; P:positive regulation of lysosomal membrane permeability; ISO:GO_Central.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IMP:MGI.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; ISO:GO_Central.
DR   GO; GO:1904592; P:positive regulation of protein refolding; ISO:GO_Central.
DR   GO; GO:0045862; P:positive regulation of proteolysis; ISO:GO_Central.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; ISO:GO_Central.
DR   GO; GO:0030163; P:protein catabolic process; ISO:GO_Central.
DR   GO; GO:0006457; P:protein folding; IDA:MGI.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:GO_Central.
DR   GO; GO:0042026; P:protein refolding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0061740; P:protein targeting to lysosome involved in chaperone-mediated autophagy; ISS:UniProtKB.
DR   GO; GO:0044743; P:protein transmembrane import into intracellular organelle; IEA:Ensembl.
DR   GO; GO:0032984; P:protein-containing complex disassembly; ISO:MGI.
DR   GO; GO:0051726; P:regulation of cell cycle; IDA:MGI.
DR   GO; GO:0099175; P:regulation of postsynapse organization; IDA:SynGO.
DR   GO; GO:0061635; P:regulation of protein complex stability; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:GO_Central.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0010045; P:response to nickel cation; IEA:Ensembl.
DR   GO; GO:1990834; P:response to odorant; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:1990832; P:slow axonal transport; IEA:Ensembl.
DR   CDD; cd10233; ASKHA_NBD_HSP70_HSPA1; 1.
DR   FunFam; 2.60.34.10:FF:000002; Heat shock 70 kDa; 1.
DR   FunFam; 3.30.420.40:FF:000172; Heat shock 70 kDa protein; 1.
DR   FunFam; 3.30.420.40:FF:000028; heat shock 70 kDa protein-like; 1.
DR   FunFam; 3.30.420.40:FF:000135; Heat shock cognate 71 kDa protein; 1.
DR   FunFam; 3.90.640.10:FF:000134; Heat shock cognate 71 kDa protein; 1.
DR   FunFam; 1.20.1270.10:FF:000003; heat shock cognate 71 kDa protein-like; 1.
DR   FunFam; 3.30.420.40:FF:000026; Heat shock protein 70; 1.
DR   FunFam; 3.30.30.30:FF:000025; Uncharacterized protein; 1.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 3.30.30.30; -; 1.
DR   Gene3D; 3.30.420.40; -; 2.
DR   Gene3D; 3.90.640.10; Actin, Chain A, domain 4; 1.
DR   Gene3D; 2.60.34.10; Substrate Binding Domain Of DNAk, Chain A, domain 1; 1.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   NCBIfam; NF001413; PRK00290.1; 1.
DR   PANTHER; PTHR19375; HEAT SHOCK PROTEIN 70KDA; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   SUPFAM; SSF100934; Heat shock protein 70kD (HSP70), C-terminal subdomain; 1.
DR   SUPFAM; SSF100920; Heat shock protein 70kD (HSP70), peptide-binding domain; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Autophagy; Cell membrane;
KW   Chaperone; Cytoplasm; Direct protein sequencing; Hydrolase;
KW   Isopeptide bond; Lysosome; Membrane; Methylation; mRNA processing;
KW   mRNA splicing; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Spliceosome; Stress response; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   CHAIN           2..646
FT                   /note="Heat shock cognate 71 kDa protein"
FT                   /id="PRO_0000078271"
FT   REGION          2..386
FT                   /note="Nucleotide-binding domain (NBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          186..377
FT                   /note="Interaction with BAG1"
FT                   /evidence="ECO:0000250"
FT   REGION          394..509
FT                   /note="Substrate-binding domain (SBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          614..646
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        616..632
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         12..15
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         14
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         15
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         71
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         202..204
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         202
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         268..275
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         268
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         271
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         275
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         339..342
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         339
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         108
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         246
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         319
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         319
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         328
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         469
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         512
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         512
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         524
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         541
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         561
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:23921388"
FT   MOD_RES         561
FT                   /note="N6,N6,N6-trimethyllysine; by METTL21A; alternate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         561
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         589
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         597
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         601
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   CROSSLNK        512
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   CROSSLNK        512
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   CONFLICT        9
FT                   /note="I -> V (in Ref. 4; BAE28187)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        35
FT                   /note="N -> K (in Ref. 4; BAE30081/BAE30861/BAE30753)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="E -> G (in Ref. 4; BAE31432/BAE31346)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        269
FT                   /note="R -> G (in Ref. 4; BAE31508)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        353
FT                   /note="F -> C (in Ref. 4; BAE31664)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        428
FT                   /note="F -> L (in Ref. 1; AAA37869 and 3; AAB18391)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        432
FT                   /note="S -> Y (in Ref. 4; BAE30707)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        589
FT                   /note="K -> E (in Ref. 5; AAH66191)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        645
FT                   /note="V -> M (in Ref. 4; BAE30272/BAE31427)"
FT                   /evidence="ECO:0000305"
FT   STRAND          7..11
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          13..22
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          36..39
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          42..44
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          49..51
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           53..57
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   TURN            58..61
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           63..65
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           70..72
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           81..86
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   TURN            87..89
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          91..97
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          100..107
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          110..114
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           116..135
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          141..146
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           152..164
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          168..174
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           175..182
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   TURN            183..186
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          187..200
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          205..213
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          216..225
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           230..249
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           257..273
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   TURN            274..276
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          278..288
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          291..298
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           299..312
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           314..324
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           328..330
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   STRAND          333..338
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           339..342
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           344..353
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   TURN            354..356
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   TURN            365..367
FT                   /evidence="ECO:0007829|PDB:3CQX"
FT   HELIX           368..380
FT                   /evidence="ECO:0007829|PDB:3CQX"
SQ   SEQUENCE   646 AA;  70871 MW;  03A27B30E6C076ED CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIISW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
